Nutrien (NTR) got here out with quarterly earnings of $2.08 per share, lacking the Zacks Consensus Estimate of $2.09 per share. This compares to earnings of $1.45 per share a 12 months in the past. These figures are adjusted for non-recurring gadgets.
This quarterly report represents an earnings shock of -0.48%. 1 / 4 in the past, it was anticipated that this producer of potash and different fertilizers would publish earnings of $0.09 per share when it really produced earnings of $0.29, delivering a shock of 222.22%.
During the last 4 quarters, the corporate has surpassed consensus EPS estimates 3 times.
Nutrien, which belongs to the Zacks Fertilizers business, posted revenues of $9.76 billion for the quarter ended June 2021, lacking the Zacks Consensus Estimate by 2.26%. This compares to year-ago revenues of $8.42 billion. The corporate has topped consensus income estimates 3 times over the past 4 quarters.
The sustainability of the inventory’s rapid worth motion based mostly on the recently-released numbers and future earnings expectations will largely rely on administration’s commentary on the earnings name.
Nutrien shares have added about 23.6% because the starting of the 12 months versus the S&P 500’s acquire of 18.1%.
What’s Subsequent for Nutrien?
Whereas Nutrien has outperformed the market to this point this 12 months, the query that involves buyers’ minds is: what’s subsequent for the inventory?
There are not any straightforward solutions to this key query, however one dependable measure that may assist buyers tackle that is the corporate’s earnings outlook. Not solely does this embody present consensus earnings expectations for the approaching quarter(s), but in addition how these expectations have modified these days.
Empirical analysis exhibits a robust correlation between near-term inventory actions and tendencies in earnings estimate revisions. Buyers can observe such revisions by themselves or depend on a tried-and-tested score software just like the Zacks Rank, which has a formidable observe report of harnessing the ability of earnings estimate revisions.
Forward of this earnings launch, the estimate revisions pattern for Nutrien was favorable. Whereas the magnitude and path of estimate revisions may change following the corporate’s just-released earnings report, the present standing interprets right into a Zacks Rank #1 (Robust Purchase) for the inventory. So, the shares are anticipated to outperform the market within the close to future. You may see the entire checklist of at present’s Zacks #1 Rank (Robust Purchase) shares right here.
It is going to be attention-grabbing to see how estimates for the approaching quarters and present fiscal 12 months change within the days forward. The present consensus EPS estimate is $0.77 on $5.38 billion in revenues for the approaching quarter and $3.84 on $24.2 billion in revenues for the present fiscal 12 months.
Buyers needs to be aware of the truth that the outlook for the business can have a cloth affect on the efficiency of the inventory as nicely. When it comes to the Zacks Business Rank, Fertilizers is at present within the high 10% of the 250 plus Zacks industries. Our analysis exhibits that the highest 50% of the Zacks-ranked industries outperform the underside 50% by an element of greater than 2 to 1.
Time to Spend money on Authorized Marijuana
Should you’re searching for massive beneficial properties, there couldn’t be a greater time to get in on a younger business primed to skyrocket from $17.7 billion again in 2019 to an anticipated $73.6 billion by 2027.
After a clear sweep of 6 election referendums in 5 states, pot is now authorized in 36 states plus D.C. Federal legalization is predicted quickly and that could possibly be a nonetheless better bonanza for buyers. Even earlier than the most recent wave of legalization, Zacks Funding Analysis has advisable pot shares which have shot up as excessive as +285.9%.
You’re invited to take a look at Zacks’ Marijuana Moneymakers: An Investor’s Information. It includes a well timed Watch Checklist of pot shares and ETFs with distinctive progress potential.
Right this moment, Obtain Marijuana Moneymakers FREE >>
Click on to get this free report
Nutrien Ltd. (NTR): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
Zacks Funding Analysis
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.